CytoGenix, Inc. and USAMRIID to Collaborate in Developing Biodefense synDNA(TM) Vaccines

HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (CYGX.OB) announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).